Shirazi F S, Moghaddam E, Mehrali M, Oshkour A A, Metselaar H S C, Kadri N A, Zandi K, Abu N A
Department of Mechanical Engineering and Advanced Material Research Center, University of Malaya, 50603, Kuala Lumpur, Malaysia.
J Biomed Mater Res A. 2014 Nov;102(11):3973-85. doi: 10.1002/jbm.a.35074. Epub 2014 Jan 6.
Calcium silicate (CS, CaSiO3 ) is a bioactive, degradable, and biocompatible ceramic and has been considered for its potential in the field of orthopedic surgery. The objective of this study is the fabrication and characterization of the β-CS/poly(1.8-octanediol citrate) (POC) biocomposite, with the goals of controlling its weight loss and improving its biological and mechanical properties. POC is one of the most biocompatible polymers, and it is widely used in biomedical engineering applications. The degradation and bioactivity of the composites were determined by soaking the composites in phosphate-buffered saline and simulated body fluid, respectively. Human osteoblast cells were cultured on the composites to determine their cell proliferation and adhesion. The results illustrated that the flexural and compressive strengths were significantly enhanced by a modification of 40% POC. It was also concluded that the degradation bioactivity and amelioration of cell proliferation increased significantly with an increasing β-CS content.
硅酸钙(CS,CaSiO3)是一种生物活性、可降解且生物相容的陶瓷,因其在骨外科领域的潜力而受到关注。本研究的目的是制备并表征β-CS/聚(1,8-辛二醇柠檬酸酯)(POC)生物复合材料,目标是控制其重量损失并改善其生物学和力学性能。POC是生物相容性最佳的聚合物之一,广泛应用于生物医学工程领域。通过将复合材料分别浸泡在磷酸盐缓冲盐水和模拟体液中来测定其降解和生物活性。在复合材料上培养人成骨细胞以测定其细胞增殖和黏附情况。结果表明,40% POC改性显著提高了复合材料的抗弯强度和抗压强度。研究还得出结论,随着β-CS含量的增加,降解生物活性和细胞增殖改善情况显著提高。